Innate Pharma
IPHA
#8378
Rank
C$0.23 B
Marketcap
$2.70
Share price
7.26%
Change (1 day)
-22.18%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -C$11.79 Million

According to Innate Pharma 's latest financial reports the company's current earnings are C$57.37 Million. In 2023 the company made an earning of -C$11.79 Million, an increase over its 2022 earnings that were of -C$87.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-C$11.79 Million-86.54%
2022-C$87.61 Million20.74%
2021-C$72.56 Million4951.09%
2020-C$1.44 Million-111.57%
2019C$12.41 M183.46%
2018C$4.38 M-105.4%
2017-C$81.17 Million-523.25%
2016C$19.17 M-285.64%
2015-C$10.33 Million-69.31%
2014-C$33.67 Million498.29%
2013-C$5.63 Million-5.62%
2012-C$5.97 Million-53.32%
2011-C$12.78 Million-50.1%
2010-C$25.6 Million-13.3%
2009-C$29.53 Million26.36%
2008-C$23.37 Million27.35%
2007-C$18.35 Million63.33%
2006-C$11.24 Million9.81%
2005-C$10.23 Million